Revolving Doors: A&O bolsters City structured finance team with Milbank hires Holly McKechnie 23 Feb 2024
‘Clients want to come to the best’: Quinn Emanuel breaks $2bn barrier with 26% revenue jump Alex Ryan 23 Feb 2024
Dealwatch: US firms lead on household names The Body Shop and Yodel as restructuring returns Elisha Juttla 22 Feb 2024
Breaking barriers: Garrigues tops €450m revenue in milestone for Euro Elite firms Anna Huntley 21 Feb 2024
‘Bolder, pragmatic, more proactive’: Regulators bare teeth, but will they bite? Holly McKechnie 16 Feb 2024
Revolving Doors: Fried Frank expands London team with Goodwin trio as Orrick faces global losses Elisha Juttla 16 Feb 2024
‘Firing on all cylinders’: Akin sees double-digit growth in revenue and PEP Holly McKechnie 16 Feb 2024
Simpson Thacher unveils new London head as office posts double-digit revenue growth Holly McKechnie 15 Feb 2024
‘It’s a differentiating year’: Hogan Lovells sees double-digit growth in revenue and PEP Elisha Juttla 13 Feb 2024
Rising stars: Jaspreet Takhar – ‘EU regulators are preparing an avalanche of new laws that are going to have a monumental impact on pharma and medtech’ Sophie Chan 9 Feb 2024
Rising stars: Dr Chris Boyle – ‘AI is going to have a transformative impact on the life sciences industry’ Sophie Chan 9 Feb 2024
Rising stars: David Gibson – ‘There are so many great new technologies and medicines with potential to make a difference to populations and treatment pathways but key challenges remain in regulating them’ Sophie Chan 9 Feb 2024
